MDT Q2 2021 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$114B

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7.6B-0.8% YoY

Gross Profit

$4.9B64.6% margin

Operating Income

$930M12.2% margin

Net Income

$489M6.4% margin

EPS (Diluted)

$0.36

QoQ Revenue Growth

+17.5%

Cash Flow

Operating Cash Flow

$1.9B

Free Cash Flow

$1.6B

Stock-Based Comp.

$140M

Balance Sheet

Total Assets

$95.9B

Total Liabilities

$45.6B

Stockholders' Equity

$50.2B

Cash & Equivalents

$6.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7.6B	$7.7B	-0.8%
Gross Profit	$4.9B	$5.3B	-7.0%
Operating Income	$930M	$1.4B	-31.2%
Net Income	$489M	$1.4B	-64.1%

Revenue Segments

Cardiac and Vascular Group

$2.7B36%

Minimally Invasive Therapies Group

$2.3B30%

Restorative Therapies Group

$2.1B27%

Diabetes Group

$574M8%

Geographic Segments

UNITED STATES

$4.1B53%

Total Other Countries, Excluding United States and Ireland

$3.6B47%

IRELAND

$24M0%